Health Sciences Research Institute Germans Trias i Pujol (IGTP), Ctra. de Can Ruti, Camí de les Escoles s/n, Badalona, Barcelona, Spain,
Cerebellum. 2014 Apr;13(2):269-302. doi: 10.1007/s12311-013-0539-y.
Intensive scientific research devoted in the recent years to understand the molecular mechanisms or neurodegeneration in spinocerebellar ataxias (SCAs) are identifying new pathways and targets providing new insights and a better understanding of the molecular pathogenesis in these diseases. In this consensus manuscript, the authors discuss their current views on the identified molecular processes causing or modulating the neurodegenerative phenotype in spinocerebellar ataxias with the common opinion of translating the new knowledge acquired into candidate targets for therapy. The following topics are discussed: transcription dysregulation, protein aggregation, autophagy, ion channels, the role of mitochondria, RNA toxicity, modulators of neurodegeneration and current therapeutic approaches. Overall point of consensus includes the common vision of neurodegeneration in SCAs as a multifactorial, progressive and reversible process, at least in early stages. Specific points of consensus include the role of the dysregulation of protein folding, transcription, bioenergetics, calcium handling and eventual cell death with apoptotic features of neurons during SCA disease progression. Unresolved questions include how the dysregulation of these pathways triggers the onset of symptoms and mediates disease progression since this understanding may allow effective treatments of SCAs within the window of reversibility to prevent early neuronal damage. Common opinions also include the need for clinical detection of early neuronal dysfunction, for more basic research to decipher the early neurodegenerative process in SCAs in order to give rise to new concepts for treatment strategies and for the translation of the results to preclinical studies and, thereafter, in clinical practice.
近年来,大量科学研究致力于理解脊髓小脑共济失调(SCA)中的分子机制或神经退行性变,这些研究正在确定新的途径和靶点,为这些疾病的分子发病机制提供新的见解和更好的理解。在这份共识文件中,作者讨论了他们目前对导致或调节 SCA 神经退行性表型的已识别分子过程的看法,其共同观点是将获得的新知识转化为治疗的候选靶点。以下是讨论的主题:转录失调、蛋白质聚集、自噬、离子通道、线粒体的作用、RNA 毒性、神经退行性变的调节剂和当前的治疗方法。总体共识点包括 SCA 神经退行性变是一种多因素、进行性和可逆转的过程,至少在早期阶段是这样。具体的共识点包括蛋白质折叠、转录、生物能量学、钙处理和神经元凋亡特征的细胞死亡的失调在 SCA 疾病进展中的作用。未解决的问题包括这些途径的失调如何引发症状的发生以及介导疾病的进展,因为这种理解可能允许在可逆转的窗口期内对 SCA 进行有效的治疗,以防止早期的神经元损伤。共同的观点还包括需要临床检测早期神经元功能障碍,进行更多的基础研究以阐明 SCA 中的早期神经退行性过程,从而为治疗策略带来新的概念,并将结果转化为临床前研究,然后转化为临床实践。